ULTIMO, Simona
 Distribuzione geografica
Continente #
NA - Nord America 963
EU - Europa 373
AS - Asia 158
OC - Oceania 5
SA - Sud America 4
AF - Africa 2
Totale 1.505
Nazione #
US - Stati Uniti d'America 960
PL - Polonia 192
CN - Cina 76
IT - Italia 69
UA - Ucraina 27
SE - Svezia 25
TR - Turchia 23
DE - Germania 20
VN - Vietnam 19
GB - Regno Unito 18
SG - Singapore 18
ID - Indonesia 13
BE - Belgio 9
FI - Finlandia 6
AU - Australia 5
BR - Brasile 3
CA - Canada 3
TW - Taiwan 3
IE - Irlanda 2
JP - Giappone 2
RO - Romania 2
SI - Slovenia 2
CL - Cile 1
EG - Egitto 1
ES - Italia 1
IN - India 1
KR - Corea 1
NG - Nigeria 1
PH - Filippine 1
TH - Thailandia 1
Totale 1.505
Città #
Warsaw 192
Fairfield 161
Woodbridge 113
Houston 92
Ann Arbor 83
Ashburn 79
Cambridge 70
Seattle 60
Chandler 59
Wilmington 52
Jacksonville 38
Ferrara 21
Izmir 21
Dong Ket 17
Nanjing 15
Beijing 14
Jakarta 13
Princeton 12
Shanghai 11
Singapore 11
Boardman 10
Los Angeles 7
Hebei 6
Nanchang 6
San Diego 6
Ghent 5
London 5
Shenyang 5
Brussels 4
Cagliari 4
Milan 4
Albuquerque 3
Changsha 3
Dearborn 3
Taipei 3
Tianjin 3
Aversa 2
Bologna 2
Casnate Con Bernate 2
Des Moines 2
Farra di Soligo 2
Focsani 2
Hangzhou 2
Hanoi 2
Mainz 2
Melbourne 2
Munich 2
New York 2
Pragersko 2
Tappahannock 2
Trieste 2
Wuhan 2
Adelaide 1
Auburn Hills 1
Bangkok 1
Braintree 1
Chicago 1
Dublin 1
Falls Church 1
Fuzhou 1
Gangnam-gu 1
Greenwich 1
Helsinki 1
Jinan 1
Kunming 1
Lanzhou 1
Liberty 1
Nagoya 1
Norwalk 1
Orange 1
Phoenix 1
Pune 1
Redmond 1
Reutlingen 1
San Jose 1
San Mateo 1
Serra 1
Villamagna 1
Xian 1
Zhengzhou 1
Totale 1.271
Nome #
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines 168
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells 162
Impact of physical exercise in cancer survivors during and after antineoplastic treatments 149
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia 147
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 146
Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia 142
Cardiovascular disease-related miRNAs expression: Potential role as biomarkers and effects of training exercise 142
Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia 138
Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments 127
Influence of physical exercise on microRNAs in skeletal muscle regeneration, aging and diseases 107
Roles and clinical implications of microRNAs in acute lymphoblastic leukemia 106
Inhibition of the PI3K/Akt/mTOR signaling pathway as a therapeutic target for Acute Lymphoblastic Leukemia 42
Totale 1.576
Categoria #
all - tutte 6.014
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.014


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020284 0 12 16 49 26 38 31 31 34 15 14 18
2020/2021499 12 17 19 20 102 62 58 51 27 84 15 32
2021/2022105 9 5 1 1 11 12 3 2 6 19 16 20
2022/2023141 13 6 13 18 17 29 7 10 17 1 5 5
2023/202482 7 9 1 3 1 4 4 10 2 4 5 32
2024/202529 14 15 0 0 0 0 0 0 0 0 0 0
Totale 1.576